A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-related Research
J Acquir Immune Defic Syndr
.
2022 Dec 15;91(5):e12-e14.
doi: 10.1097/QAI.0000000000003084.
Epub 2022 Sep 2.
Authors
Danielle M Campbell
1
2
,
Portia D Cowlings
2
3
,
Martha Tholanah
4
,
Mallery Jenna Robinson
5
,
Gail Graham
6
,
Scovia Aseru
7
,
Karine Dubé
8
,
Susan E Cohn
9
,
Katharine J Bar
10
,
Elizabeth Connick
11
,
Rosie Mngqbisa
12
,
Eileen P Scully
13
,
Jamila K Stockman
14
,
Sara Gianella
14
Affiliations
1
Joint Doctoral Program in Public Health, University of California, San Diego/San Diego State University, La Jolla, CA.
2
Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA.
3
Department of Education, Graduate School of Education and Psychology, Pepperdine University, Los Angeles, CA.
4
Milton Park Clinical Research Site, Community Advisory Board, University of Zimbabwe Clinical Trials Research Center, Milton Park.
5
Trans Excellence Academy and Transgender Empathy Trainings, Los Angeles, CA.
6
Johns Hopkins University AIDS Clinical Trials Group Clinical Research Site, Community Advisory Board, Baltimore, MD.
7
Joint Clinical Research Centre (JCRC)/Kampala Clinical Research Site, Kampala, Uganda.
8
UNC Gillings School of Global Public Health, Chapel Hill, NC.
9
Infectious Diseases Division, Feinberg School of Medicine, Northwestern University, Chicago, IL.
10
University of Pennsylvania, Philadelphia, PA.
11
University of Arizona, Tuscon, AZ.
12
Durban International Clinical Research Site, AIDS Clinical Trials Group, Durban, South Africa.
13
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD.
14
Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA.
PMID:
36083494
PMCID:
PMC9646409
DOI:
10.1097/QAI.0000000000003084
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Female
HIV Infections* / drug therapy
HIV Infections* / prevention & control
Humans
Grants and funding
UM1 AI164570/AI/NIAID NIH HHS/United States
UL1 TR001442/TR/NCATS NIH HHS/United States
P01 AI169609/AI/NIAID NIH HHS/United States
R25 MH067127/MH/NIMH NIH HHS/United States
R01 MH126768/MH/NIMH NIH HHS/United States
P30 MH062512/MH/NIMH NIH HHS/United States
T32 DA023356/DA/NIDA NIH HHS/United States
P30 AI036214/AI/NIAID NIH HHS/United States
R21 MH118120/MH/NIMH NIH HHS/United States